Quantcast

Saturday, November 1, 2008

Rimonibant banned in Europe

The European Medicines Agency (EMEA) has banned the new antiobesity drug rimonabant in European Union. EMEA has suspended the marketing authorisation as the benefits no longer outweigh the risks of psychiatric adverse effects.

Free Books, powerpoint presentations, teaching tools and resources and drug information